Successful treatment with tocainide of recessive generalized congenital myotonia
- 1 May 1986
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 19 (5), 501-504
- https://doi.org/10.1002/ana.410190515
Abstract
A patient with recessive generalized congenital myotonia and severe, disabling weakness underwent various forms of treatment while being monitored electrophysiologically. Phenytoin, verapamil, and acetazolamide were ineffective, but tocainide yielded good results. Improvement was dose-dependent, and was limited by irritability and action tremor when the patient was taking 1,600 mg per day.This publication has 11 references indexed in Scilit:
- Myotonia, Paramyotonia and Periodic ParalysisPublished by Springer Nature ,1985
- The quantification of myotoniaJournal of the Neurological Sciences, 1983
- Autosomal recessive generalized myotoniaMuscle & Nerve, 1983
- Transient paresis in myotonic syndromes: A simplified electrophysiologic approachMuscle & Nerve, 1982
- Advances in Antiarrhythmic TherapyPublished by American Medical Association (AMA) ,1982
- Improved therapy of myotonia with the lidocaine derivative tocainideZeitschrift für Neurologie, 1980
- Effects of acetazolamide on myotoniaAnnals of Neurology, 1978
- Long-term tocainide therapy for ventricular arrhythmias.Circulation, 1978
- Transient muscular weakness in severe recessive myotonia congenitaZeitschrift für Neurologie, 1978
- Muscle weakness after rest in myotonic disorders: an electrophysiological studyJournal of Neurology, Neurosurgery & Psychiatry, 1974